Skip to main content
. 2011 Sep 6;103(18):1387–1396. doi: 10.1093/jnci/djr283

Figure 1.

Figure 1

CONSORT diagram of study participants in long-term follow-up study on cervical neoplasia, including carcinoma in situ (CIS) and invasive cervical cancer (ICC). At the baseline examination in 1991–1992, 11 923 participants (aged 30–65 years) consented to human papillomavirus (HPV) testing and cytology (Pap); following the exclusions noted, 6923 participants were reexamined in 1993–1995. Women who developed cervical cancer were identified from cancer and death registries, permitting calculation of cumulative risk related to baseline status and also related to the combination of results from baseline and second examinations. Only women who were initially normal were included for the analyses for baseline HPV infection (n = 10123) and repeated HPV testing (n = 6666).